ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery

Affiliations

¹ Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
² Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
³ Pediatrics Unit, Vithas Almería, Instituto Hispalense de Pediatría, Almería, Andalusia, Spain.
⁴ Department of Pediatrics Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
⁵ AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
⁶ Department of Woman and Child's Health, University of Padova, Padova, Italy.
⁷ Department of Pediatrics, Life Groenkloof Hospital, Pretoria, South Africa.
⁸ Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
⁹ Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
¹⁰ Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Review

Jennifer L Sherr et al. Pediatr Diabetes. 2022 Dec.

. 2022 Dec;23(8):1406-1431.

doi: 10.1111/pedi.13421. Epub 2022 Dec 5.

¹ Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
² Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
³ Pediatrics Unit, Vithas Almería, Instituto Hispalense de Pediatría, Almería, Andalusia, Spain.
⁴ Department of Pediatrics Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
⁵ AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
⁶ Department of Woman and Child's Health, University of Padova, Padova, Italy.
⁷ Department of Pediatrics, Life Groenkloof Hospital, Pretoria, South Africa.
⁸ Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
⁹ Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
¹⁰ Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.

No abstract available

Keywords: automated insulin delivery; connected pens; diabetes technology; insulin pumps.

References

1. Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes Clinical Guidelines. Diabetes Care. 2013;36(7):2035-2037. doi:10.2337/dc12-1959
1. McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050. doi:10.1111/dme.12676
1. Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi:10.1089/dia.2018.0384
1. Anderzen J, Hermann JM, Samuelsson U, et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-a quality registry study. Pediatr Diabetes. 2020;21(4):621-627. doi:10.1111/pedi.13014
1. Hermann JM, Miller KM, Hofer SE, et al. The transatlantic HbA1c gap: differences in glycaemic control across the lifespan between people included in the US T1D exchange registry and those included in the German/Austrian DPV registry. Diabet Med. 2020;37(5):848-855. doi:10.1111/dme.14148